Kidney Transplant Rejection Market is Driven by Rising ESRD Cases
The kidney transplant rejection market encompasses a diverse portfolio of therapies designed to prevent and treat immune-mediated rejections that threaten graft survival in renal transplant recipients. Core products include calcineurin inhibitors, mTOR inhibitors, monoclonal antibodies, cellular therapies, and emerging gene-editing and RNA-interference candidates. These agents offer advantages...
0 Комментарии 0 Поделились 54 Просмотры 0 предпросмотр